United Urology Kidney Stone Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.15 M
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2006
- Satisfied Charges ₹ 6.30 M
About United Urology Kidney Stone Centre
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110TZ1994PTC005465
-
Company No.
005465
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Nov 1994
-
Date of AGM
16 Aug 2006
-
Date of Balance Sheet
31 Mar 2006
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at United Urology Kidney Stone Centre?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manickam Ramalingam
|
Director | 01-Nov-1994 | Current |
|
William Moses
|
Director | 13-Aug-2000 | Current |
|
Palanisamy Thirumalaisamy
|
Director | 24-Aug-1996 | Current |
|
Shanmugam Natarajan
|
Director | 24-Aug-1996 | Current |
|
Ganapathy Migar
|
Director | 24-Aug-1996 | Current |
|
Periasami Palanisami
|
Director | 01-Nov-1994 | Current |
Financial Performance of United Urology Kidney Stone Centre.
Enhance accessibility to United Urology Kidney Stone Centre's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of United Urology Kidney Stone Centre?
Unlock access to United Urology Kidney Stone Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Kovai Uro Nephro And Cancer Centre Private LimitedManickam Ramalingam is a mutual person
Charges (Loans)
₹0
₹6.30 M
Charges Breakdown by Lending Institutions
- The Catholic Syrian Bank Ltd. : 0.30 Cr
- The Catholic Syrian Bank Ltd : 0.30 Cr
- Catholic Syrian Bank Ltd : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2001 | Catholic Syrian Bank Ltd | ₹0.30 M | Satisfied |
| 21 Mar 1996 | The Catholic Syrian Bank Ltd | ₹3.00 M | Satisfied |
| 21 Mar 1995 | The Catholic Syrian Bank Ltd. | ₹3.00 M | Satisfied |
How Many Employees Work at United Urology Kidney Stone Centre?
Unlock and access historical data on people associated with United Urology Kidney Stone Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of United Urology Kidney Stone Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped United Urology Kidney Stone Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.